Heterohybridoma for the production of non murine monoclonal antibodies
Hybridoma technology described by kohler and Milstein produce only mouse immunoglobulins. Such immunoglobulins have limited use due to its negative side effects such as the recipient’s immune response. The production of a non murine monoclonal antibody to combat the problems of murine...
Main Author: | Kh.Victoria Chanu and M. Ayub Ali |
---|---|
Format: | Article |
Language: | English |
Published: |
Veterinary World
2010-01-01
|
Series: | Veterinary World |
Subjects: | |
Online Access: | http://www.scopemed.org/mnstemps/2/2-1286562301.pdf |
Similar Items
-
Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
by: Jakub Radocha, et al.
Published: (2021-03-01) -
Two new murine monoclonal antibodies rised against human IgG
by: Petrićević Marijana, et al.
Published: (2001-01-01) -
Two new murine monoclonal antibodies rised against human IgG
by: RATKO M. JANKOV, et al.
Published: (2001-05-01) -
Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01) -
Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True
by: Mattia D’Agostino, et al.
Published: (2020-11-01)